PL-15 the protein C pathway in cancer metastasis

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Spek, C Arnold ^a   Arruda, Valder R ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

APC; Cancer; Coagulation; Metastasis; Protein C

Indexed keywords

ACTIVATED PROTEIN C; ENZYME PRECURSOR; PROTEIN C; THROMBOMODULIN; BLOOD CLOTTING FACTOR;

BLOOD CLOTTING; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CONFERENCE PAPER; DRUG TARGETING; HUMAN; IN VITRO STUDY; METASTASIS; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; HUMANS; NEOPLASM METASTASIS; PROTEIN C; SIGNAL TRANSDUCTION;

EID: 84862151690     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70022-1     Document Type: Conference Paper

References (79)

1. S Bouillaud De l'obliteration des veines et de son influence sur la formation des hydropisies partielles: considerations sur l'hydropisie passive et generale Arch Gen Med 1 1823 188 204
2. HR Buller, FF van Doormaal, GL van Sluis, PW Kamphuisen Cancer and thrombosis: from molecular mechanisms to clinical presentations J Thromb Haemost 5 Suppl 1 2007 246 254 (Pubitemid 46958840)
3. Trousseau, A. Phlegmasia alba dolens. Clinique medicale de l'Hotel-Dieu de Paris, 1865:654-712.
4. A Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 2007 1723 1729 (Pubitemid 47443881)
5. HK Chew, T Wun, D Harvey, H Zhou, RH White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
6. JW Blom, CJM Doggen, S Osanto, FR Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 (Pubitemid 40216041)
7. M Carrier, GG Le, PS Wells, D Fergusson, T Ramsay, MA Rodger Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149 2008 323 333
8. A Falanga, A Piccioli Effect of anticoagulant drugs in cancer Curr Opin Pulm Med 11 2005 403 407 (Pubitemid 41291083)
9. FR Rickles, A Falanga Molecular basis for the relationship between thrombosis and cancer Thromb Res 102 2001 V215 V224
10. SM Smorenburg, R Vink, HM Otten, F Swaneveld, HR Büller The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis Thromb Haemost 86 2001 1586 1587 (Pubitemid 34007540)
11. P Prandoni, AW Lensing, HR Büller, M Carta, A Cogo, M Vigo, D Casara, A Ruol, JW ten Cate Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis Lancet 339 1992 441 445
12. RJ Hettiarachchi, SM Smorenburg, J Ginsberg, M Levine, MH Prins, HR Büller Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread Thromb Haemost 82 1999 947 952
13. M Altinbas, HS Coskun, O Er, Ozkan, B Eser, A Unal, M Cetin, S Soyuer A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 2004 1266 1271 (Pubitemid 40186120)
14. AK Kakkar, MN Levine, Z Kadziola, V Lemoine NR Low, HK Patel, G Rustin, M Thomas, M Quigley, RC Williamson Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 2004 1944 1948 (Pubitemid 41095187)
15. CPW Klerk, SM Smorenburg, HM Otten, AW Lensing, MH Prins, F Piovella, P Prandoni, MM Bos, DJ Richel, G van Tienhoven, HR Büller The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2005 2130 2135 (Pubitemid 46218704)
16. FF van Doormaal, M Di Nisio, HM Otten, DJ Richel, M Prins, HR Buller Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer J Clin Oncol 29 2011 2071 2076
17. FF van Doormaal, HR Büller Heparin and survival in cancer patients Hematol Oncol Clin North Am 24 2010 777 784
18. ML Nierodzik, F Kajumo, S Karpatkin Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo Cancer Res 52 1992 3267 3272
19. ML Nierodzik, A Plotkin, F Kajumo, S Karpatkin Thrombin stimulates tumorplatelet adhesion in vitro and metastasis in vivo J Clin Invest 87 1991 229 236
20. L Hu, M Lee, W Campbell, R Perez-Soler, S Karpatkin Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis Blood 104 2004 2746 2751 (Pubitemid 39434957)
21. A Amirkhosravi, SA Mousa, M Amaya, JL Francis Antimetastatic effect of tinzaparin, a low-molecular-weight heparin J Thromb Haemost 1 2003 1972 1976
22. HQ Miao, M Elkin, E Aingorn, R Ishai-Michaeli, CA Stein, I Vlodavsky Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides Int J Cancer 83 1999 424 431 (Pubitemid 29455768)
23. JL Stevenson, SH Choi, A Varki Differential metastasis inhibition by clinically relevant levels of heparins - correlation with selectin inhibition, not antithrombotic activity Clin Cancer Res 11 2005 7003 7011 (Pubitemid 41428760)
24. LW Bruggemann, HH Versteeg, TM Niers, PH Reitsma, CA Spek Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders J Cell Mol Med 12 2008 2622 2627
25. CT Esmon The Protein C Pathway Chest 124 2003 26S 232
26. JH Griffin, B Evatt, TS Zimmerman, AJ Kleiss, C Wideman Deficiency of protein C in congenital thrombotic disease J Clin Invest 68 1981 1370 1373 (Pubitemid 12235040)
27. AW Broekmans, JJ Veltkamp, RM Bertina Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families N Engl J Med 309 1983 340 344
28. CF Allaart, SR Poort, FR Rosendaal, PH Reitsma, RM Bertina, E Briët Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect Lancet 41 1993 134 138 (Pubitemid 23029305)
29. EM Conway, RD Rosenberg Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells Mol Cell Biol 8 1988 5588 5592
30. HE Branson, J Katz, R Marble, JH Griffin Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant Lancet 2 1983 1165 1168 (Pubitemid 14243933)
31. U Seligsohn, A Berger, M Abend, L Rubin, D Attias, A Zivelin, SI Rapaport Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn N Engl J Med 310 1984 559 562 (Pubitemid 14193095)
32. RA Marlar, RR Montgomery, AW Broekmans Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the working party on homozygous protein C deficiency of the ICTH-Subcommittee on protein C and protein S Thromb Haemost 61 1989 529 531 (Pubitemid 19168170)
33. AK Lindahl, MC Boffa, U Abildgaard Increased plasma thrombomodulin in cancer patients Thromb Haemost 69 1993 112 114 (Pubitemid 23041178)
34. AM Hanly, M Redmond, DC Winter, S Brophy, JM Deasy, DJ Bouchier-Hayes, EW Kay Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival Br J Cancer 94 2006 1320 1325
35. AM Hanly, DC Winter The role of thrombomodulin in malignancy Semin Thromb Hemost 33 2007 673 679 (Pubitemid 350157011)
36. Y Matsushita, K Yoshiie, Y Imamura, H Ogawa, H Imamura, S Takao, S Yonezawa, T Aikou, I Maruyama, E Sato A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone-thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma Cancer Lett 127 1998 195 201 (Pubitemid 28230804)
37. SJ Kim, E Shiba, H Ishii, T Inoue, T Taguchi, Y Tanji, Y Kimoto, M Izukura, S Takai Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study Anticancer Res 17 1997 2319 2323 (Pubitemid 27320990)
38. N Tsuneyoshi, K Fukudome, S Horiguchi, X Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines Thromb Haemost 85 2001 356 361 (Pubitemid 32140584)
39. M Bezuhly, R Cullen, CT Esmon, SF Morris, KA West, B Johnston, RS Liwski Role of activated protein C and its receptor in inhibition of tumor metastasis Blood 113 2009 3371 3374
40. TA Mewhort-Buist, PC Liaw, S Patel, HM Atkinson, LR Berry, AK Chan Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma Thromb Res 122 2008 418 426
41. J Woodley-Cook, LYY Shin, L Swystun, S Caruso, S Beaudin, PC Liaw Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway Mol Cancer Ther 5 2006 3303 3311 (Pubitemid 46092074)
42. SE Feffer, LS Carmosino, RL Fox Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil Cancer 63 1989 1303 1307 (Pubitemid 19084550)
43. JS Rogers, AJ Murgo, JA Fontana, PC Raich Chemotherapy for breast cancer decreases plasma protein C and protein S J Clin Oncol 6 1988 276 281 (Pubitemid 18065931)
44. W Ruf PAR1 signaling: more good than harm? Nat Med 9 2003 258 260 (Pubitemid 36362775)
45. M Uchiba, K Okajima, Y Oike, Y Ito, K Fukudome, H Isobe, T Suda Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo Circ Res 95 2004 34 41 (Pubitemid 38931833)
46. LM Beaulieu, FC Church Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1 Exp Cell Res 313 2007 677 687 (Pubitemid 46198814)
47. JS Bae, L Yang, AR Rezaie Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells Proc Natl Acad Sci USA 104 2007 2867 2872 (Pubitemid 46327971)
48. DE Joyce, L Gelbert, A Ciaccia, B DeHoff, BW Grinnell Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis J Biol Chem 276 2001 11199 11203 (Pubitemid 38089304)
49. MW Gramling, LM Beaulieu, FC Church Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction Exp Cell Res 316 2010 314 328
50. T Cheng, D Liu, JH Griffin, JA Fernandez, F Castellino, ED Rosen, K Fukudome, BV Zlokovic Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective Nat Med 9 2003 338 342 (Pubitemid 36362790)
51. H Guo, D Liu, H Gelbard, T Cheng, R Insalaco, JA Fernández, JH Griffin, BV Zlokovic Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3 Neuron 41 2004 563 572 (Pubitemid 38253068)
52. LA O'Brien, MA Richardson, SF Mehrbod, DT Berg, B Gerlitz, A Gupta, BW Grinnell Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR-independent mechanism involving Egr-1/Erk-1/2 activation Arterioscler Thromb Vasc Biol 27 2007 2634 2641 (Pubitemid 350158916)
53. M Riewald, RA Schuepbach Protective signaling pathways of activated protein C in endothelial cells Arterioscler Thromb Vasc Biol 28 2008 1 3
54. GL Van Sluis, TMH Niers, CT Esmon, W Tigchelaar, DJ Richel, HR Buller, CJ Van Noorden, CA Spek Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement Blood 114 2009 1968 1973
55. M Riewald, W Ruf Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling J Biol Chem 280 2005 19808 19814 (Pubitemid 41379506)
56. C Feistritzer, M Riewald Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation Blood 105 2005 3178 3184
57. F Niessen, C Furlan-Freguia, JA Fernandez, LO Mosnier, FJ Castellino, H Weiler, H Rosen, JH Griffin, W Ruf Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality Blood 113 2009 2859 2866
58. GL van Sluis, LW Brüggemann, CT Esmon, PW Kamphuisen, DJ Richel, HR Büller, CJ van Noorden, CA Spek Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation Cancer Lett 306 2011 106 110
59. H Weiler-Guettler, PD Christie, DL Beeler, AM Healy, WW Hancock, H Rayburn, JM Edelberg, RD Rosenberg A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state J Clin Invest 101 1998 1983 1991 (Pubitemid 28226118)
60. AW Rijneveld, S Weijer, S Florquin, CT Esmon, JC Meijers, P Speelman, PH Reitsma, H Ten Cate, T van der Poll Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide Blood 103 2004 1702 1709 (Pubitemid 38268962)
61. NA Horowitz, EA Blevins, WM Miller, AR Perry, KE Talmage, ES Mullins, MJ Flick, KC Queiroz, K Shi, CA Spek, EM Conway, BP Monia, H Weiler, JL Degen, JS Palumbo Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain Blood 118 2011 2889 2895
62. L Bajzar, R Manuel, ME Nesheim Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor J Biol Chem 270 1995 14477 14484
63. A Reijerkerk, JC Meijers, SR Havik, BN Bouma, EE Voest, MF Gebbink Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice J Thromb Haemost 2 2004 769 779 (Pubitemid 40185716)
64. M Levi Activated protein C in sepsis: a critical review Curr Opin Hematol 15 2008 481 486
65. JS Bae, L Yang, C Manithody, AR Rezaie The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells Blood 110 2007 3909 3916 (Pubitemid 350248446)
66. TM Niers, LW Bruggemann, GL van Sluis, RD Liu, HH Versteeg, HR Büller, CJ van Noorden, PH Reitsma, CA Spek, DJ Richel Long-term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis J Thromb Haemost 7 2009 1595 1597
67. GL Van Sluis, M Nieuwdorp, PW Kamphuisen, J van der Vlag, CJ Van Noorden, CA Spek A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx PLoS One 5 2010 e11200
68. H Yamaguchi, J Kitayama, N Takuwa, K Arikawa, I Inoki, K Takehara, H Nagawa, Y Takuwa Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells Biochem J 374 2003 715 722 (Pubitemid 37163916)
69. H Rosen, EJ Goetzl Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network Nat Rev Immunol 5 2005 560 570 (Pubitemid 40961333)
70. G Schmid, M Guba, I Ischenko, A Papyan, M Joka, S Schrepfer, CJ Bruns, KW Jauch, C Heeschen, C Graeb The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1 J Cell Biochem 101 2007 259 270 (Pubitemid 46652589)
71. AF Shorr, GR Bernard, JF Dhainaut, JR Russell, WL Macias, DR Nelson, DP Sundin Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome Crit Care 10 2006 R92
72. B White, W Livingstone, C Murphy, A Hodgson, M Rafferty, OP Smith An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia Blood 96 2000 3719 3724
73. RC Clarke, JR Johnston, EE Mayne Meningococcal septicaemia: treatment with protein C concentrate Intensive Care Med 26 2000 471 473 (Pubitemid 30301531)
74. F Baratto, F Michielan, M Meroni, PA Dal, A Boscolo, C Ori Protein C concentrate to restore physiological values in adult septic patients Intensive Care Med 34 2008 1707 1712
75. M Crivellari, VP Della, G Landoni, F Pappalardo, C Gerli, E Bignami, G Marino, A Zangrillo, A D'Angelo Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery Intensive Care Med 35 2009 1959 1963
76. L Decembrino, A D'Angelo, F Manzato, A Solinas, F Tumminelli, A De Silvestri, S De Lazzari, E Padovani, M Magarotto, L Chiandetti, SO Saia, M Stronati Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study Shock 34 2010 341 345
77. E Messaris, AP Betrosian, N Memos, E Chatzigianni, M Boutsikou, V Economou, I Dontas, G Theodossiades, MM Konstadoulakis, EE Douzinas Administration of human protein C improves survival in an experimental model of sepsis Crit Care Med 38 2010 209 216
78. D Frommhold, J Tschada, N Braach, K Buschmann, A Doerner, J Pflaum, MS Stahl, H Wang, L Koch, M Sperandio, A Bierhaus, B Isermann, J Poeschl Protein C concentrate controls leukocyte recruitment during inflammation and improves survival during endotoxemia after efficient in vivo activation Am J Pathol 179 2011 2637 2650
79. G Nilsson, S Hojgard, E Berntorp Treatment of the critically ill patient with protein C: Is it worth the cost? Thromb Res 125 2010 494 500